Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, Week Ending December 20, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Tarveda Therapeutics, Inc Organovo Holdings, Inc. N/A Immune Therapeutics, Inc. Aletheia Therapeutics Corp. N/A eHealth Acquirer Target Price VerityStream CredentialMyDoc $9,000,000 Home Health Care & Hospice Acquirer Target Price... Read More »Private Equity Stormed PMG Sector in 2019
Even with just our preliminary data, private equity dominated dealmaking in the Physician Medical Groups (PMG) sector in 2019. According to our Deal Search Online database, PE firms and their portfolio companies (PE Buyers) accounted for roughly 71% of M&A activity in the sector, or 152 deals. And although we found dealmaking in nearly every specialty, from OB/GYN to radiology, it was heavily concentrated in three particular fields: dermatology, dental, and ophthalmology. Source: HealthcareMandA.com, December 2019 There were 49 deals focused on ophthalmology practices in 2019, a significant jump over every other specialty, and it was a select group of buyers driving the deal volume.... Read More »
Autism Therapy Tops PE’s List in December
A good number of behavioral health care deals have been announced in Decmeber 2019 and the majority of those target companies providing therapy services to individuals with autism and intellectual and developmental disabilities (I/DD). Seven deals in the Behavioral Health Care sector are on the books mid-way through the month and five offer some form of applied behavior analysis (ABA) therapy or services. The two remaining deals target companies specializing in residential substance abuse treatment and inpatient addiction and eating disorders for teens. Thomas H. Lee Partners announced the only deal to disclose a price. The firm paid $415 million (16.6x EBITDA) for Centria Healthcare, a... Read More »
Top 10 Healthcare Services Deals 2010-2019
What a decade it’s been for health care! The Affordable Care Act, enacted in 2010, unleased a tidal wave of change on the U.S. healthcare landscape that continues today. Even on the services side, pharmaceuticals figured into several transactions, from acquiring pharmacy benefits managers and contract research organizations (the R&D angle) to wholesale and distribution. With only a few days left in the decade, here’s a chart of the top 10 healthcare services deals announced since January 1, 2010, ranked by disclosed price. Five of the top 10 deals were announced in the last three years, including CVS Health’s (NYSE: CVS) $78 billion shocker targeting Aetna,... Read More »
Humana Doubles Down on Hospice Services
Humana Inc. (NYSE: HUM) is moving more deeply into hospice care with its recent announcement that it will acquire Philadelphia-based Enclara Healthcare from Consonance Capital Partners and Enclara management. Enclara is one of the largest hospice and pharmacy benefit management (PBM) providers in the country, serving 450 hospice providers and 97,000 hospice patients daily. This deal includes mail-order pharmacy Enclara Pharmacia, specialty PBM GuidantRx and pharmacy Avanti Health Care Services. Enclara’s palliative care provider, Turn-Key Health, is not included. Consonance first invested in Enclara in 2014 and added ExcelleRx, PGM Holdings and Avanti Health Care Services in the... Read More »
Diplomat Pharmacy, under Pressure, Merges with OptumRx
In early November, Diplomat Pharmacy, Inc. (NYSE: DPLO) revealed some troubling news. The company reported a net loss of $177.3 million in its third-quarter earnings report, its third in a row, and issued a “going concern” warning. Shares dropped 50% (from $6.20 to $3.10) that morning. Brian Griffin, chairman and CEO of Diplomat, cited industry headwinds pressuring its prescription benefits management (PBM) business, and its failure to renew network participation in their specialty pharmacy network. Diplomat’s PBM segment generated $82 million in Q3:19, compared to $170 million in the same quarter last year. Diplomat Pharmacy’s efforts to expand in the PBM sector... Read More »eHealth Deals Soar in 2019
It almost goes without saying that technology has permeated every aspect of healthcare, but dealmaking in 2019 underscores that point even further. Based on preliminary numbers, eHealth deals hit a record 212 this year, a slight uptick from 2018’s deal count of 204, according to our Deal Search Online database. Source: HealthcareMandA.com, December 2019 The graph above breaks out the number of deals by target type. Companies focused on providing management software solutions to support back-office operations led the sector this year, with 46 deals. These are usually small firms offering software-as-a-service (SaaS) platforms that could be implemented to aid any type of healthcare... Read More »
Tenet Sells Two Hospitals for $350 Million
In its first sale of 2019, Tenet Healthcare Corporation (NYSE: THC) is divesting two of its Memphis-area hospitals to Methodist Le Bonheur Healthcare, which operates six acute-care and one children’s hospital in and around Memphis. The not-for-profit health system will pay $350 million in cash for Saint Francis Hospital-Memphis (353 beds) and Saint Francis Hospital-Bartlett (156 beds), the physician practices associated with both hospitals, and six MedPost urgent care centers. The transaction is expected to be completed in 2020. The agreement provides that Tenet’s Conifer Health Solutions subsidiary will continue to provide revenue cycle management services to the hospitals.... Read More »
Health Care M&A Deals, Week Ending December 13, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price Acorn Health Behavior Therapy Specialists N/A Biotechnology Acquirer Target Price Sanofi Synthorx, Inc. $2,500,000,000 Merck & Co., Inc. ArQule, Inc. $2,700,000,000 eHealth Acquirer Target Price InSight Telepsychiatry... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
